The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / RheumPAC: Advance Rheumatology on Capital Hill

RheumPAC: Advance Rheumatology on Capital Hill

April 13, 2011 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Levin (right) and other ACR advocates during a visit to Capitol Hill.
Dr. Levin (right) and other ACR advocates during a visit to Capitol Hill.

One way to succeed in our mission of advancing rheumatology is to increase the ACR’s presence on Capitol Hill through grassroots and direct lobbying. However, for the rheumatology subspecialty to be most effective we must use all tools available to us, including RheumPAC, the ACR’s nonpartisan political action committee. RheumPAC demonstrates to members of Congress that the rheumatology subspecialty is committed to political action, educating policy makers, and improving healthcare for our patients.

You Might Also Like
  • RheumPAC Supports Two Candidates Who Support Rheumatology
  • RheumPAC: One Year, One Contribution, One Opportunity
  • RheumPAC Supports Those Who Support Rheumatology
Explore This Issue
April 2011
Also By This Author
  • Social Networking with Our Patients

RheumPAC provides opportunities for the ACR to educate Congress on the importance—and especially the value—of rheumatology. Recently, ACR President David Borenstein, MD, attended a small dinner event for Sen. Orrin Hatch (R-UT). As the ranking member on the Senate Finance Committee and a member of the Health, Education, Labor, and Pensions Committee, Senator Hatch will play a key role in developing health policy in the 112th Congress. During the event, Dr. Borenstein had the opportunity to personally discuss many issues affecting the rheumatology community including the elimination of consultation codes, a permanent fix to the Sustainable Growth Rate, and the importance of arthritis research.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Attending these small events allows ACR representatives to personalize our message and begin building relationships with key legislators in addition to furthering knowledge of rheumatology among policymakers. RheumPAC members along with other members of the ACR plan to meet with members of Congress throughout the year to continue the dialogue on the role rheumatology plays in care coordination, improved patient outcomes, and the importance of cognitive specialties.

With the changes in Congress, having a strong RheumPAC is more important than ever. RheumPAC will continue outreach to returning members of Congress and the newly elected U.S. senators and representatives. If we want to fulfill our mission and advance rheumatology, we must have a strong presence in Washington, D.C. Find out how you can get involved or to learn more about RheumPAC, visit www.rheumatology.org/advocacy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Why I’m an Advocate

“I have supported RheumPAC for the past several years because I recognize the need for the ACR to have a presence on Capitol Hill. Financially supporting influential people in Congress assists the ACR in its advocacy efforts by providing more opportunities to meet with members of Congress and educate them on rheumatology-related issues. All rheumatology professionals benefit when the ACR is involved. RheumPAC makes these opportunities possible. This is one way we can strengthen our position and visibility, and improve our chance of having influence over the critical decisions made by Congress that affect all rheumatologists.”

Pages: 1 2 | Single Page

Filed Under: From the College, Legislation & Advocacy Tagged With: AC&R, Advocacy, Congress, Legislation, Politics, RheumPACIssue: April 2011

You Might Also Like:
  • RheumPAC Supports Two Candidates Who Support Rheumatology
  • RheumPAC: One Year, One Contribution, One Opportunity
  • RheumPAC Supports Those Who Support Rheumatology
  • What Has RheumPAC Done for You Lately?

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)